| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | MTD Mettler Toledo International Inc/ | Filliol Olivier A71 | Director | Sell | 10,000 | $1,545.51 | $15,455,093.14 | -7.9% | -10.3% | -23.6% | |
| Feb 14, 2023 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 11,600 | $574.14 | $6,659,968.14 | -0.6% | -8.4% | -4.1% | |
| Feb 14, 2023 | IQV Iqvia Holdings Inc. | Sherbet Eric57 | See Remarks | Sell | 1,000 | $230.00 | $230,000.00 | -5.5% | -15.7% | +7.2% | |
| Feb 14, 2023 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 2,000 | $1,557.50 | $3,115,000.00 | -13.2% | -10.3% | -23.6% | |
| Feb 13, 2023 | MTD Mettler Toledo International Inc/ | Aggersbjerg Peter54 | Head Of Divisions | Sell | 648 | $1,515.26 | $981,888.48 | -100% | -10.8% | -25.5% | |
| Feb 13, 2023 | MTD Mettler Toledo International Inc/ | Keller Gerry64 | Head Of Process Analytics | Sell | 474 | $1,540.69 | $730,287.48 | -27.9% | -10.8% | -25.5% | |
| Feb 13, 2023 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 1,892 | $1,550.37 | $2,933,293.36 | -16.0% | -10.8% | -25.5% | |
| Feb 13, 2023 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 4,527 | $64.55 | $292,217.85 | -0.4% | +23.7% | -9.1% | |
| Feb 13, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,372 | $26.18 | $219,188.24 | -0.8% | -9.3% | -11.2% | |
| Feb 13, 2023 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 1,158 | $64.55 | $74,748.90 | -5.3% | +23.7% | -9.1% | |
| Feb 10, 2023 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 40,000 | $572.31 | $22,892,293.32 | -1.2% | -7.3% | -3.6% | |
| Feb 10, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 19,582 | $15.85 | $310,314.22 | -1.8% | -45.4% | -42.6% | |
| Feb 9, 2023 | TWST Twist Bioscience Corp | Starovasnik Melissa A. | Director | Sell | 1,732 | $26.46 | $45,820.06 | -13.2% | -46.5% | +54.8% | |
| Feb 9, 2023 | TWST Twist Bioscience Corp | Johannessen Jan71 | Director | Sell | 1,732 | $26.46 | $45,820.06 | -13.0% | -46.5% | +54.8% | |
| Feb 9, 2023 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 16,278 | $1.80 | $29,285.75 | -7.5% | -6.3% | +5.7% | |
| Feb 9, 2023 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 1,999 | $1.80 | $3,596.40 | -8.0% | -6.3% | +5.7% | |
| Feb 9, 2023 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 4,220 | $1.80 | $7,592.20 | -4.1% | -6.3% | +5.7% | |
| Feb 9, 2023 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 1,852 | $1.80 | $3,331.93 | -1.9% | -6.3% | +5.7% | |
| Feb 9, 2023 | BDSX Biodesix Inc | Siurek Ryan H64 | Chief Accounting Officer | Sell | 2,016 | $1.80 | $3,626.99 | -6.9% | -6.3% | +5.7% | |
| Feb 8, 2023 | CDNA Caredx, Inc. | Maag Peter84 | Director | Sell | 3,269 | $15.75 | $51,500.81 | -1.1% | -45.8% | -44.0% | |
| Feb 8, 2023 | XGN Exagen Inc. | Adawi Kamal | CFO And Corporate Secretary | Sell | 5,821 | $2.69 | $15,670.71 | -6.0% | +5.9% | -26.7% | |
| Feb 8, 2023 | XGN Exagen Inc. | Hazeltine Mark | Chief Business Officer | Sell | 5,821 | $2.69 | $15,672.46 | -5.8% | +5.9% | -26.7% | |
| Feb 7, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 3,069 | $16.40 | $50,337.43 | -0.5% | -50.4% | -47.5% | |
| Feb 3, 2023 | MDXH Mdxhealth SA | Mvm Partners, LLC | 10% Owner | Buy | 1,000,000 | $4.00 | $4,000,000.00 | +2.2% | -4.9% | -0.5% | |
| Feb 3, 2023 | TMO Thermo Fisher Scientific Inc. | Manzi Jim P52 | Director | Sell | 1,000 | $584.56 | $584,558.64 | -3.2% | -7.2% | -6.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.